Detail page

Knowledge Web

Person

Marc Schmalzing (1974-)

Arzt

Name	Marc Schmalzing
Time	1974- (Date of birth and death)
Place	Deutschland
Academic degree	Dr. med. (Univ. Erlangen-Nürnberg) (2001) Priv.-Doz.
Profession	Arzt (characteristic profession) Internist
Variant	Marc Thomas Schmalzing
Further information	Habilitation Fach Innere Medizin an der Medizinischen Fakultät der Univ. Würzburg (2020)
Source	Subgruppenspezifische Therapiestrategien bei rheumatisch-entzündlichen Erkrankungen - 2020 Klinik-website: https://www.ukw.de/mitarbeiter/name/schmalzing-marc/ (Stand: 19.02.2021)
Record type	Person
GND-Identifier	123290422
Record ID	123290422
Involved in show all Intraorbital findings in giant cell arteritis on black blood MRI Morbus Castleman in der rheumatologischen Praxis = Castleman’s disease in the rheumatological practice Intraorbital findings in giant cell arteritis on black blood MRI Intraorbital findings in giant cell arteritis on black blood MRI Vasa vasorum of proximal cerebral arteries after dural crossing - potential imaging confounder in diagnosing intracranial vasculitis in elderly subjects on black-blood MRI Vasa vasorum of proximal cerebral arteries after dural crossing — potential imaging confounder in diagnosing intracranial vasculitis in elderly subjects on black-blood MRI A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol Januskinase-Inhibition - ein neues Therapieprinzip bei Autoimmunerkrankungen Older age onset of systemic sclerosis - accelerated disease progression in all disease subsets Subgruppenspezifische Therapiestrategien bei rheumatisch-entzündlichen Erkrankungen Versorgungsrealität der stationären vasoaktiven Therapie mit Prostazyklinderivaten bei Patienten mit akralen Durchblutungsstörungen bei systemischer Sklerose in Deutschland = Reality of inpatient vasoactive treatment with prostacyclin derivatives in patients with acral circulation disorders due to systemic sclerosis in Germany Addition or removal of concomitant methotrexate alters adalimumab effectiveness in rheumatoid arthritis but not psoriatic arthritis Entwicklung von Hammerhead-Ribozymen zur Hemmung der Expression von RAS-Onkogenen in Plasmazell-Linien

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Marc Schmalzing (1974-)

Intraorbital findings in giant cell arteritis on black blood MRI

Morbus Castleman in der rheumatologischen Praxis = Castleman’s disease in the rheumatological practice

Intraorbital findings in giant cell arteritis on black blood MRI

Intraorbital findings in giant cell arteritis on black blood MRI

Vasa vasorum of proximal cerebral arteries after dural crossing - potential imaging confounder in diagnosing intracranial vasculitis in elderly subjects on black-blood MRI

Vasa vasorum of proximal cerebral arteries after dural crossing — potential imaging confounder in diagnosing intracranial vasculitis in elderly subjects on black-blood MRI

A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol

Januskinase-Inhibition - ein neues Therapieprinzip bei Autoimmunerkrankungen

Older age onset of systemic sclerosis - accelerated disease progression in all disease subsets

Subgruppenspezifische Therapiestrategien bei rheumatisch-entzündlichen Erkrankungen

Addition or removal of concomitant methotrexate alters adalimumab effectiveness in rheumatoid arthritis but not psoriatic arthritis

Entwicklung von Hammerhead-Ribozymen zur Hemmung der Expression von RAS-Onkogenen in Plasmazell-Linien